GLIMITERIS TRIO 0.3 is a combination medication containing Voglibose (0.3 mg), Glimepiride (3 mg), and Metformin Hydrochloride (500 mg). This formulation is primarily used for managing type 2 diabetes mellitus. It works synergistically to control blood glucose levels effectively, providing comprehensive glycemic control.

How Does It Work?

• Voglibose: Inhibits enzymes responsible for breaking down carbohydrates into glucose, reducing post-meal blood sugar spikes.
• Glimepiride: Stimulates the pancreas to release more insulin, helping lower blood glucose levels.
• Metformin Hydrochloride: Reduces glucose production in the liver and improves insulin sensitivity, facilitating better glucose uptake by cells.

Uses of GLIMITERIS TRIO 0.3

• Effective management of type 2 diabetes mellitus
• Helps achieve and maintain target blood glucose levels
• Reduces the risk of diabetes-related complications

What is GLIMITERIS TRIO 0.3?

GLIMITERIS TRIO 0.3 is a fixed-dose combination medication used to treat type 2 diabetes. It combines three different antidiabetic agents, each with a unique mechanism of action, providing a comprehensive approach to managing blood sugar levels.

Side Effects

• Hypoglycemia (low blood sugar)
• Gastrointestinal issues like nausea, vomiting, and diarrhea
• Dizziness or lightheadedness
• Weight gain (common with glimepiride)
• Skin reactions or rashes

Safety Information

• Monitor blood sugar levels regularly to avoid hypoglycemia.
• Inform your doctor of any existing medical conditions, especially kidney or liver problems.
• Avoid excessive alcohol consumption as it can affect blood sugar control.
• Follow a balanced diet and exercise regimen as recommended by your healthcare provider.
• Do not take this medication if you are allergic to any of its components.

If You Need More Information About GLIMITERIS TRIO 0.3 Click here